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Abstract
The design of novel a-helix mimetic inhibitors of protein-protein interactions is of interest to pharmaceuticals and chemical
genetics researchers as these inhibitors provide a chemical scaffold presenting side chains in the same geometry as an a-
helix. This conformational arrangement allows the design of high affinity inhibitors mimicking known peptide sequences
binding specific protein substrates. We show that GAFF and AutoDock potentials do not properly capture the
conformational preferences of a-helix mimetics based on arylamide oligomers and identify alternate parameters matching
solution NMR data and suitable for molecular dynamics simulation of arylamide compounds. Results from both docking and
molecular dynamics simulations are consistent with the arylamides binding in the p53 peptide binding pocket. Simulations
of arylamides in the p53 binding pocket of hDM2 are consistent with binding, exhibiting similar structural dynamics in the
pocket as simulations of known hDM2 binders Nutlin-2 and a benzodiazepinedione compound. Arylamide conformations
converge towards the same region of the binding pocket on the 20 ns time scale, and most, though not all dihedrals in the
binding pocket are well sampled on this timescale. We show that there are two putative classes of binding modes for
arylamide compounds supported equally by the modeling evidence. In the first, the arylamide compound lies parallel to the
observed p53 helix. In the second class, not previously identified or proposed, the arylamide compound lies anti-parallel to
the p53 helix.
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Introduction
Background
The interaction between the E3 ubiquitin ligase hDM2 and a
helical peptide forming part of the p53 tumor suppressor domain is
of great interest as a target for protein-protein interaction
inhibition [1]. Researchers have shown this interaction regulates
the tumour suppression function of p53 and thus inhibiting this
interaction could be used to treat various types of cancers [1].
Several drugs targeting this interaction are in clinical trials [2].
The system is well studied from a biochemical perspective [3], and,
importantly for this study, there is a wealth of structural data
giving insight into the mechanism of p53 recognition by hDM2[4–
6].
High quality X-ray structural data for the hDM2-p53 system
exists. This complex is representative of several helix-mediated
protein-protein interactions [7] and has thus served as a popular
model system. The hDM2 protein structure was first solved in
complex with a 15-mer wild-type p53 peptide
(SQETFSDLWKLLPEN) by Kussie et al. [4]. The peptide was
show to bind in an a-helical conformation to a cleft on hDM2 with
key side chains Phe 19, Trp 23 and Leu 26 from p53 making key
contacts with hDM2. Grasberger and colleagues determined the
structure of a p53 related helix that had been optimized to bind
hDM2 with higher affinity than the wild-type helix [5]. The nine-
mer high affinity peptide (RFMDYWEGL) retains the key binding
pattern Phe-Trp-Leu that targets the deep hydrophobic pocket
present on the hDM2 surface. The wild-type helix is 15 residues
long and has a calculated binding affinity (Kd) of 600 nM [4]. It
has been shown that in general shorter helices containing the
conserved Phe-Trp-Leu motif will bind more tightly [8].
Small-molecule inhibitors of the hDM2-p53 interaction have
also been discovered and their atomic structures published [6,9].
One class of compounds that inhibits hDM2 by targeting the p53
pocket is the Nutlins. In 2004, Fry et al. published the NMR
structure of Xenopus Laevis hDM2 bound to a small-molecule
inhibitor [9] belonging to this Nutlin family described in the work
by Vassilev et al. [6]. Vassilev et al. published the structure of
hDM2 in complex with a cis-imidazoline compound to 2.3 Å
resolution [6]. The authors screened a diverse range of compounds
identifying the cis-imidazoline compounds as promising lead
compounds. One of these compounds, Nutlin-2, was measured
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to have an IC50 of 0.14 mM. An improved IC50 of 0.09 mM was
determined from an enantiomer of a related compound called
Nutlin-3a, and specificity was demonstrated via the 200-fold lower
affinity of the enantiomer Nutlin-3b [6].
Helix-mediated PPIs such as p53-hDM2 represent a class of
interaction within the wider family of PPIs that may be amenable
to the elaboration of general approaches for small molecule
modulation [7]. Hence, the structure of the hDM2 binding pocket
has been widely investigated both experimentally and computa-
tionally because it has features that suggest it is a ‘druggable’
protein-protein interface [10]. NMR studies of the hDM2 binding
pocket show the unbound structure to be flexible [11]. McInnes
et al. specifically note that on binding there is rearrangement of
residues in the p53 binding site compared to the NMR structure of
the apo protein. The flexibility of the binding site brings into
question whether it is possible to use structure-based methods to
design protein-protein interaction inhibitors given only the apo
structure of protein binding partners. Eyrisch and Helms
previously investigated three protein-protein interactions including
the hDM2-p53 interaction using molecular dynamics simulations
and the PASS algorithm for pocket detection [12]. They
concluded that ligand binding pockets are observed opening and
closing over tens of picoseconds in their nanosecond simulations
[12]. Carotti et al. studied the hDM2 and related hDMX system
computationally to attempt to identify key residues involved in p53
binding [13]. They used 60 ns MD simulations to investigate
structural changes between the bound and unbound forms of each
protein. In these simulations they identified that a change in
conformation of Tyr 99 from hDM2 results in a decrease in hDM2
solvent accessible surface area (SASA) when moving from the apo
to bound states [13].
There have also been many experimental efforts to design
inhibitors of the hDM2-p53 interaction. Experimental high
throughput screening (HTS) methods in combination with use of
crystal structures identified the initial inhibitors of the hDM2
interaction. Wang and co-workers used the GOLD docking
program to identify spiro-oxyindole-based scaffolds that could
inhibit the hDM2-p53 interaction with micromolar affinities [14],
successfully identifying several novel inhibitors of hDM2. Peptide
libraries developed using phage display technologies have been
used to find novel peptide binders for hDM2 [15]. This technique
has many advantages due to its ability to screen large libraries of
peptides with similarities to the p53 peptide relatively inexpen-
sively [15].
Several computational studies attempting to identify key binding
site features and compute ligand binding free energies have been
performed previously, although often over timescales of less than
5 ns for individual trajectories[16–19]. Massova and Kollman
studied the hDM2-p53 interaction using a technique that they
developed named computational alanine scanning [16]. They used
an MM-PBSA model to estimate the free energy change required
to mutate a side-chain to alanine. This allowed them to propose
key residues contributing to the binding energy and identified a
direct correlation between the energy and the frequency of
accepted mutations in homologous p53 peptides. Similar work was
performed by Kortemme and Baker, using a simple model using
empirical statistical potentials [17]. They identified residues on
both the p53 peptide and the hDM2 binding site that contribute
significantly to binding free energy with results correlating with the
free energies estimated by Massova and Kollman. These studies
suggest that simulations of hDM2 can provide useful information
on the hDM2-p53 interaction.
Novel classes of inhibitors of protein-protein interactions, such
as the hDM2-p53 interaction, are of great interest due to the
involvement of such interactions in a number of disease pathways.
A variety of generic templates have been described as inhibitors of
such helix mediated PPIs [7], including constrained peptides [20],
b [21], or a/b-peptides [22] and proteomietics [23]. Proteomi-
metics are non-natural scaffolds that present functional groups in a
similar 3D arrangement to natural protein side chains; such
scaffolds can in theory be used to modulate any protein-protein
interaction of interest. In this study, we computationally investi-
gate the binding of arylamides, foldamer compounds designed to
mimic the p53 transactivation domain a-helix and competitively
inhibit the hDM2-p53 interaction [24,25]. 3-alkoxysubstituted-
para-oligoarylamides adopt a rod-like conformation that can
present side-chains at locations similar to those at the i, i+4, i+7
locations on an a-helix [26]. These side-chain locations corre-
spond to the Phe-Trp-Leu residues identified as hot-spot residues
for the hDM2-p53 interaction. The compounds investigated in this
study are synthetically accessible using an iterative approach that
sequentially couples then reduces 4-nitro-3-alkoxybenzoic acid
monomers. [27] A representative X-ray structure of these
arylamide compounds revealed an intramolecular hydrogen bond
between the amide NH and ether oxygen [27]. This finding is
mirrored in results from solution NMR of the arylamide
compound in deuterated DMSO-d6 and CDCl3 [27]. 2D
1H–1H NOESY spectra, indicating that there is free rotation
about the ArCO bond. This intramolecular hydrogen bonding
restricts rotation about the ArNH bond [27]. Model arylamide
dimers show similar configurational preferences [28].
Further work by Plante et al. showed that arylamide compounds
can act as low mM inhibitors of the hDM2-p53 interaction [26].
Shaginian et al. described the synthesis of a library containing a
diverse series of these arylamide compounds [29]. A limited
docking study was performed by Shaginian et al. identifying
configurations presenting the arylamide side chains coincident
with the locations of the p53 Phe-Trp-Leu side chains. In the work
by Plante et al. six arylamides were synthesized and screened
against the hDM2-p53 interaction using a fluorescence anisotropy
assay, showing that the compounds inhibited the hDM2-p53
interaction with IC50’s of between 10 mM and 1 mM [26].
However, there are no published structures of hDM2 in complex
with an arylamide compound, which motivated this study to
identify putative models of the complex.
Computational studies have also helped us understand the
properties of arylamide compounds. A quantum mechanics study
of the torsional profile of arylamide compounds calculated the
location of minima and the heights of barriers between minima for
the Ca-Ca-C-N, Ca-Ca-N-C dihedral angles, data required to
identify force field parameters that can accurately model the
arylamide [30]. Molecular dynamics has been used to investigate
the behavior of arylamide compounds designed to mimic heparin
in solution. For example, Pophristic et al. identified problems with
adequately sampling certain arylamide backbone conformations
using standard molecular dynamics approaches and used an
enhanced sampling technique to attempt to overcome the
problems [31]. Vemparala and co-workers noted that altering
the thioether to an ether group is one way in which the flexibility
of the compound could be controlled, since the larger thioether
group would reduce backbone flexibility [30].
Work Carried Out in this Study
As there are no published structures of any hDM2-arylamide
complexes, computational insights into this complex can signifi-
cantly aid design of improved arylamide inhibitors. In this study
we use molecular docking to generate conformations of arylamide
compounds bound to hDM2. We identify appropriate parameters
p53 Peptide Helix Mimetics Can Bind in Two Ways
PLOS ONE | www.plosone.org 2 August 2012 | Volume 7 | Issue 8 | e43253
that result in experimentally observed arylamide backbone
torsional preferences. We then analyze these conformations and
use the best ranked ones to perform molecular dynamics
calculations of the bound systems. We use these molecular
dynamics simulations to test whether hDM2-arylamide complexes
behave similarly to p53-hDM2 complexes or other small-molecule
inhibitor complexes. We then analyze dynamics of the arylamide
dihedral angles and spatial sampling in the hDM2 binding pocket
to identify problems in the configurations found by molecular
docking. These molecular dynamics simulations also allow us to
identify how long simulations of hDM2 bound to arylamides may
need in order to reach convergence, and whether a single bound




We performed structural superposition of proteins with UCSF
Chimera version 1.4 on the Mac OS X operating system using the
MatchMaker function with default settings [32], in order to
compare binding modes between peptides and small-molecule
ligands. The hDM2 chains (1Z1M-model 9, 1YCR-chain A,
1T4F-chain M, 1RV1-chain A, 1T4E-chain B) were superposed
using the MatchMaker algorithm, while the bound ligands–where
present–were subjected to the same rotation and translation as
their partner proteins. The ligand is therefore retained in the same
position relative to partner protein, and all ligands can be
compared in their common binding site.
Docking
There are no known structures for hDM2 bound to arylamide
compounds. However, computational docking of these compounds
to hDM2 generates physically reasonable complexes that can be
further evaluated using molecular dynamics. Two rounds of
docking using Autodock were performed [33,34]. The first round
was used to assess the performance of the Autodock force field,
whereas the second round was used to generate plausible
conformations of the hDM2-arylamide interaction. In both
docking rounds, random number seeds were generated from the
Autodock PID and the current system time. The protein structure
used was derived from the structure of hDM2 bound to a high-
affinity p53 peptide (1T4F-chain M), with all water molecules and
the helix removed, protonation states manually assigned taking
into account the local hydrogen bonding network in the vicinity of
histidines which can have multiple protonation states at pH 7. A
grid centered on 13.119, 18.969, 10.941 was used with spacing of
0.375 Å and 52, 58 and 48 points in the x, y and z directions.
In the first round of docking, we used Autodock 4.0 to perform
2.5 million evaluations for 27,000 generations with population size
300 to produce 101 docked conformations. The results from this
set of dockings were clustered at a 2 Å RMS cutoff. The lowest
energy representative structures of these clusters were used in the
initial MD simulations and are representatives from the largest low
energy clusters labeled clu1, clu2, clu3 (Figure S1 in Text S1). The
second round of docking calculations were performed with
Autodock 4.2.1 using a Lamarkian genetic algorithm. 150 docked
conformations were generated, with each using 25 million
evaluations for 27,000 generations of population size 300. We
also used the docking program FRED (OpenEye, version 2.2.5) to
see if the results were independent of docking program. FRED is a
rigid body docking program, meaning that conformations of the
molecule to be docked are generated prior to docking. Confor-
mations for the arylamide compounds were generated using the
OMEGA (OpenEye, version 2.2.1) conformational generator,
supplied by OpenEye. OMEGA uses an energy window of 25 to
generate a maximum of 1 million conformers (maxconfgen), of
which a maximum of 10000 with RMSD of greater than 0.5 Å
between previously generated conformers were kept (maxconfs).
150 docked poses were generated, with all settings not mentioned
left as default.
Preparation of Structures for Molecular Dynamics
All structures were taken from the Protein Data Bank (PDB)
[35]. In cases where multiple chains were present, a single hDM2
chain was selected: 1T4E-A; 1T4F-M; 1YCR-A; 1RV1-A; 1Z1M
model 9. We selected the corresponding bound ligand where
appropriate: 1T4E-A; 1T4F-P; 1YCR-B; 1RV1-A. All water
molecules were removed from the crystal structures and proton-
ation states were manually assigned using the same criteria as
described in the section ‘Docking’. Ligand molecules were
parameterized with GAFF parameters and AM1BCC charges
using the default settings from the acpype front end to
Antechamber [36–38]. The grompp program from Gromacs
was used to assign AMBER99sb force field parameters from the
ffamber ports [39–42].
GAFF parameters for the ArCO and ArNH dihedral angles in
the arylamide compounds were replaced by those reported by
Vemparala et al. [30], since we were predominantly interested in
the correct location of minima in the torsions. Work by Liu et al.
(published after the computations in this study were performed)
validates the choice of these modified parameters for the ArNH
bond (–SCH3 containing model arylamide compounds) for the
ArNH dihedral for the arylamide compound in this study (–OCH3
functional group) [43]. Liu et al. showed that the potential energy
profile of the ArNH dihedral follows the same dihedral pattern for
model compounds containing the –OCH3 and –SCH3 functional
groups bonded to the benzamide ring, with barrier heights within
1 kcal mol21 for both compounds [43].
MD Simulations of p53 and Small-molecule Inhibitors of
HDM2
In order to determine whether our molecular dynamics protocol
is appropriate for simulating the hDM2 system, including the
specific force field choice of AMBER99sb/GAFF, we first
performed simulations of hDM2 inhibitors of known structures.
Initial MD simulations were performed using Gromacs 3.3.1 [41].
All structures were minimized to a tolerance of 100 kJ mol21
nm21 with an initial step size of 0.01 nm for a maximum of 5000
steps of L-BFGS minimization with 10 correction steps, followed
by a maximum of 500 steps of steepest descent minimization due
to occasional early terminations of the Gromacs implementation of
L-BFGS. Minimization was followed by 10 ps of isothermal
dynamics followed by 100 ps of isothermal/isobaric equilibration
using the Berendsen algorithms [44]. Production simulations were
run for a total of 10 ns. In the latter two stages pressure coupling
was performed using a Berendsen barostat with reference pressure
of 1 atm, compressibility of 4.561025 bar21 and relaxation time of
0.5 ps. All simulations used the Gromacs stochastic integrator (sd)
with reference temperature 300 K and relaxation time 0.1 ps for
the entire system, with a step size of 2 fs. PME parameters are
from Mobley et al. [45], with PME spline order of 6, relative
tolerance of 161026 and a Fourier spacing of 0.1 nm. A long-
range dispersion correction is also applied for energy and pressure
to correct for the truncation of the long-range dispersive
interactions. A Lennard-Jones function with switching between
0.8 nm and 0.9 nm was used for the van der Waals interactions.
The neighbor list was set to 1 nm and updated every 10 simulation
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steps. All bonds with H-atoms were constrained using the LINCS
algorithm with highest order expansion of the constraint coupling
matrix of 12. SETTLE was used to constrain water bonds and
angles.
Arylamide MD Simulations
We used molecular dynamics simulations to investigate the
dynamics of the hDM2 binding site and compounds with known
structures of hDM2 complexes. Molecular dynamics simulations
were performed using Gromacs, version 4.0.4 [42]. Simulations
were performed using conformations generated from the second
round of Autodock docking (5 anti-parallel and 4 parallel
conformers labeled conf. 1, 2, 3, 7, 8 and conf. 4, 9, 10, 11
respectively). All docked structures were minimized to a tolerance
of 100 kJ mol21 nm21 with an initial step size of 0.01 nm for a
maximum of 5000 steps of L-BFGS minimization with 10
correction steps, followed by a maximum of 2000 steps of steepest
descent minimization. Minimization was followed by 10 ps of
isothermal dynamics followed by 100 ps of isothermal/isobaric
equilibration using the Berendsen algorithms. Production simula-
tions were run for 20 ns each. In the latter two stages pressure
coupling was performed using a Parrinello-Rahman barostat with
reference pressure of 1 atm, compressibility of 4.561025 bar21
and relaxation time of 5.0 ps.
As previously described for the MD simulations of p53 and
small-molecule inhibitors of hDM2, data for the hDM2/arylamide
complexes was generated using simulations using the stochastic
integrator with reference temperature 300 K and temperature
relaxation time 0.1 ps for the entire system, with a step size of 2 fs.
All PME, long-range dispersion, cutoff, neighbor list, and
constraint parameters were the same as with other Gromacs
simulations in this study.
Analysis of Gromacs Simulations
Molecular dynamics simulations were first analyzed to check for
convergence in several standard properties such as temperature
and energy. Gromacs simulations were then analyzed using four
key measures: the RMSD from the initial structure (after two
rounds of minimization) throughout the time-course of the
simulation (using the g_rms tool); the RMSF of individual residue
Ca atoms from the initial structure after two rounds of
minimization (using the g_rmsf tool); the number of intermolecular
pairs of atoms between hDM2 and the ligand that are with 3.5 Å
(using the g_hbond tool); and the difference in the distance
between the center of mass of the hDM2 molecule and the bound
ligand molecule compared to the initial structure after two rounds
of minimization (using the g_dist tool).
Dihedral Analysis
Dihedral angles were monitored during the simulations, as it
is known that dihedrals are often not well sampled even in
extremely long time-scale simulations of protein-ligand binding
sites [46]. The distribution of dihedral angles over 20 ns of
production simulation is plotted for each x angle for all residues
contacting the ligand and each dihedral present in the
arylamide. Additionally, the starting value of each dihedral is
marked on the distribution. We analyzed the distributions,
identifying dihedral angles sampled in many simulations but
missing in other simulations. Angles are labeled as: ‘well
sampled’ where all simulations sample the same distribution;
‘mostly well sampled’ where all but one simulation samples the
same distribution, or some peaks are considerably different in
height but still sampled and located at the same angle; and
‘possible sampling problem’ where peaks are missing from more
than one simulation indicating that some starting conformations
can access dihedral angles that others may not be able to
access.
Autocorrelation Analysis
We computed the autocorrelation function of the cosine of
the dihedral angles to compare the timescale of these dihedral
rotations to the timescale of our simulations. Autocorrelation
functions of length 10 ns (from simulations of length 20 ns) were
generated for each x angle from hDM2 binding residues for 5
anti-parallel and 4 parallel starting conformations of the Phe-
Nap-Leu compound. The autocorrelation function was fit to an
exponential of the form y = exp(2x/t) using the g_chi program
from Gromacs 4.0.4 [42]. Numerical integration of the
exponential, also carried out using g_chi, yields the relaxation
time for the x angle.
Orientation and Positioning of Arylamide Compounds in
the HDM2 Binding Pocket
Investigating the orientation of the arylamide compounds
relative to the hDM2 binding pocket allows us to ask whether
the ligands in all simulations tend to converge to the same region
of space in the pocket. This would indicate strongly that there is a
clear preferred binding mode and additionally mean that the
choice of starting configuration for simulations is less important.
Spatial sampling was analyzed by projecting the position of each of
the three ether oxygen atoms of the arylamide from 20 ns
simulations at time intervals of 10 ps onto a plane defined by the
Ca atoms of Tyrosine 56, Methionine 62 and Valine 93. These
three atoms lie in the periphery of the binding site and define a
plane that cuts through the site at a roughly constant depth. A
Python program using the Numpy toolkit was written solving the
equation describing the intersection of a line l, and a plane p:
laz lb{lað Þt~p0z p1{p0ð Þuz p2{p0ð Þv
This algorithm calculates the projection along the direction
normal to the ligand plane containing the point (lb) and an ether
oxygen atom at position la (defining a line (lb–la)t) onto the plane
defined by the Ca atoms of the protein (p) at p0 (point defined by
Ca Tyr 56), the line defined by (p1–p0)u (where p1 is the point
defined by Ca Met 62), and the line defined by (p2–p0)v (where p2
is the point defined by Ca Val 93).
Cluster Analysis of Arylamide Conformations
The Gromacs 4.0.4 program g_cluster was used to generate
clusters with a minimum RMSD of 1.5 Å. The clustering method
takes a random structure from the pool of structures and identifies
all structures within the RMSD threshold, defining a cluster. The
structure with the most neighbors from the largest cluster is
selected as the group center, and this structure and all of its cluster
members are removed from the pool. The procedure is repeated
until the pool of structures is empty and all structures are assigned
to clusters [47]. Cluster size (number of members of each cluster),
and cluster membership was generated for the pooled conforma-
tions taken at 10 ps intervals between 3 ns and 20 ns from 5 anti-
parallel (1, 2, 3, 7, 8) starting conformations. 3 ns is chosen as the
point where temperature, pressure and other short timescale
fluctuations had equilibrated. The same was repeated for the 4
parallel (4, 9, 10, 11) starting conformations.
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Results and Discussion
We first address the suitability of the MMFF94, Autodock and
GAFF force fields for modeling arylamide compounds and using
molecular docking to generate hDM2-arylamide complexes. We
then describe the results of molecular dynamics simulations on
these putative complexes to help validate the bound configurations
of arylamide compounds in the hDM2 binding pocket and provide
an insight into arylamide binding. We assess the sampling quality
of hDM2 arylamide interactions examining side chain dihedrals of
binding site residues and of arylamide compounds, arylamide
conformational clustering, and orientation and positioning of
arylamide compounds in the hDM2 binding pocket. Besides
providing understanding of the structural interactions of these
ligands, these simulations also highlight the importance of proper
sampling in both docking and molecular dynamics with respect to
previously performed studies.
Force Fields Describing the Behavior of Arylamide
Compounds
We observed that conformers generated by OMEGA described
the non-standard behavior of the ArCO and ArNH bonds when
using the MMFF94 force field, reported experimentally by Plante
et al. and Prabhakaran et al., and in-silico by Vemparala et al.
[27,28,30]. While AutodockTools correctly identified the amide
bond present in the arylamide compound as rigid, it could not
describe the planar conformation of the ArNH torsion and the free
rotation about the ArCO bond (Figure S2 in Text S1). The
position of the ArNH torsion in Figure S2 lies at the peak of a
metastable region identified by Vemparala et al. Furthermore, QM
calculations showed that the torsion angle is about 6 kcal/mol
greater in energy than its most stable energy minimum, thus an
unlikely conformation [30]. Using the parameters from the
thioether compound previously studied by Vemparala et al. the
ArNH and ArCO torsion conformational preferences are
described much more accurately. Indeed, the use of these
thioether parameters in place of ether parameters has been
validated by a study published since the simulations that we report
were carried out [43]. As a result, all further Autodock
computations restrained the arylamide with the ArNH dihedral
oriented so that the amide hydrogen can form the intramolecular
hydrogen bonds with the ether oxygen that are observed in X-ray
structure and NMR data of the uncomplexed ligand [27,28].
Molecular Dynamics Simulation of an Arylamide
Compound in Solution
Comparing molecular dynamics simulations of an arylamide
compound in solution with and without the dihedral-modified
GAFF parameters show that our modified GAFF parameters
describe the experimentally observed free rotation about the
arylamide ArCO bond, whereas the unmodified GAFF parame-
ters do not show free rotation about the ArCO bond. Prabhakaran
et al. published 2D 1H–1H NOESY NMR spectra of 2-O-alkylated
arylamide model compounds, with napthyl, isobutyl or benzyl side
groups [28]. From the presence of NOEs between the NH and
aromatic protons on the adjacent ring they were able to observe
free rotation about the ArCO bond. However, the lack of an NOE
from the NH to the anilide ring confirms that the ArNH torsion is
restrained by hydrogen bonding to the ether oxygen. We used a 1/
r3 distance average from our 20 ns trajectories to allow qualitative
comparison to the 2D 1H–1H NOESY NMR spectra presented by
Prabhakaran et al. and we use the same nomenclature for the H2,
H5 and H6 protons (see Figure 1) [28]. Using the unmodified
GAFF force field the distances between the amide proton and the
adjacent aromatic benzamide protons were 1.8 Å and 4.4 Å
respectively, so one would expect to observe an H2 NOE but not
an H6 NOE. The absence of an H6 NOE is in contradiction to the
NMR data, and shows that free rotation around the ArCO bond is
not possible when using the unmodified GAFF parameters. The
amide proton to benzamide H5 proton distance is 3.3 Å which
shows that the ArNH bond has restricted ability to rotate when
using the unmodified GAFF parameters. For MD simulations
using the modified GAFF parameters, comparing the 1/r3 average
distances observed for protons from the arylamide scaffold
containing the carboxy-terminal Leu mimic, and the central Trp
mimic, we observed that the distance between the amide proton
and the H2 and H6 benzamide protons was 2.5 Å and 2.4 Å
respectively. Since the simulations show that both H2 and H6
distances are equivalently small one would expect to observe both
H2 and H6 NOEs. The presence of both H2 and H6 NOEs is
indeed in agreement with NMR data and indicates that free
rotation around the ArCO bond is possible when using the
modified GAFF parameters. The MD simulations using modified
GAFF parameters show that the 1/r3 average distance between
the amide proton and the adjacent H5 benzamide proton is 3.3 Å
which shows that the ArNH bond has restricted ability to rotate as
is observed in the NMR experiments of Prabhakaran et al. [28].
Structural Superposition Shows that Current Small-
molecule Inhibitors Bind in a Manner Similar to the p53
Peptide
Key to any study of the hDM2-arylamide protein-ligand
complex is an accurate structure for the protein-ligand complex.
Ideally this would come from X-ray or NMR structures; however,
no such structures exist for arylamides. However, as discussed
earlier in the case of hDM2, there is an NMR structure of the free
protein in addition to high-resolution X-ray structures of the
protein bound to a wild-type p53 helix, a high-affinity p53 helix, a
benzodiazepinedione compound and Nutlin-2. The former two
are peptides while the latter two are small-molecules specifically
designed to target this interaction.
Structural superposition of different hDM2 protein-ligand
complexes reveals that the two reported inhibitors benzodiazepi-
nedione and Nutlin-2 target the same regions of the binding
pocket as the high-affinity p53 peptide, mimicking the interaction
of Phe-Trp-Leu side-chains from the p53 peptide as seen in
Figure 2. Both series of inhibitors were discovered through
independent high-throughput screens. They both have scaffolds
that allow the presentation of their key functional groups in very
similar spatial locations to the high-affinity peptide, indicating that
use of a common backbone to design inhibitors is likely a useful
strategy.
In Figure 2b, we can see that the Nutlin-2 compound closely
mimics the binding mode of the high-affinity p53 helix. The two
chlorophenyl groups target the Leu and Trp pockets and the
arylethyl ether moiety binds in the Phe pocket. The crystal
structure of hDM2 bound to a high-affinity helix was reported at
the same time as a 2.6 Å structure of hDM2 bound to a
benzodiazepinedione compound. The benzodiazepinedione com-
pound also mimics the same Phe-Trp-Leu binding mode as the
p53 peptides as shown in Figure 2c. Grasberger et al. noted that
the inhibitor interacts with the hDM2 binding pocket through non-
specific van der Waals contacts. Because of these patterns, when
targeting the hDM2 binding pocket with arylamide based helix
mimetics we expect that high-affinity compounds should also
target these same structural features [5].
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Figure 1. 2D Structure of the arylamide backbone. a) hydrogen bonding pattern with free rotation of the third oligomer around the ArCO
bond as shown by the arrow. In this case the amide H–H3 and the amide H–H6 can both be in close proximity, but the H–H5 protons can not. This
pattern was observed in NMR experiments and dihedral-modified GAFF parameter MD simulations. In b), no hydrogen bond forms leading to free
rotation of the third residue around the ArNH bond. In this case the amide H–H3 and the amide H–H5 protons can both be in close proximity, but the
amide H–H6 protons can not. This pattern was observed in the unmodified GAFF parameter MD simulations of arylamides, but not in NMR
experiments.
doi:10.1371/journal.pone.0043253.g001
Figure 2. Superposition of the ligand bound hDM2 structures. Benzodiazepinedione and Nutlin-2 compounds both target the same regions
of space corresponding to the Phe-Trp-Leu motif from p53. Representations of high affinity helix (green) shown relative to: a) wild type helix; b)
Nutlin-2; c) Benzodiazepinedione compound. Figures were generated using the matchmaker function from Chimera to superpose hDM2 from PDB
code 1T4F to pdb codes: a) 1YCR; b) 1RV1; c) 1T4E.
doi:10.1371/journal.pone.0043253.g002
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Molecular Docking Supports the Putative Binding
Location
Due to the lack of experimental data on the structure of the
hDM2-arylamide interaction we have used two molecular
docking programs in addition to using an alternative superpo-
sition based method (Figure S3 in Text S1). Our key
assumption, based on the evidence presented in the section
‘Structural superposition shows that current small-molecule
inhibitors bind in a manner similar to the p53 peptide’, in
creating our docking model is that since the four compounds for
which we have high resolution structures available all bind to
the same site, this site is where the arylamide compounds are
most likely to bind. These compounds also experimentally
displace the helix from hDM2 [23,26]. Furthermore, since the
arylamide compounds have been designed to mimic the side-
chains present at positions i, i+4, i+7 on an a-helix, we expect
to find arylamide substituents bound at these sites. This is
supported by structural superposition of the hDM2 protein from
the putative docked arylamide structures to the hDM2 protein
from the p53 peptide bound structure, allowing comparison of
the relative location of the arylamide compound and the p53
peptide (Figure S1 in Text S1). Since there are no structures of
immediately similar compounds to the arylamides in which we
were interested, and there is no data about binding affinities for
many of these compounds, we were limited in our ability to
assess the quality of the results produced by docking programs.
We generated 150 docked poses, with the ArNH dihedral
restrained to preferred low energy conformations identified by
OMEGA, to select a small number of compounds for use in
MD simulations of the hDM2 binding site. We identified three
possible docking modes from the top three low energy clusters
using a 2 Å RMS clustering threshold. The resulting
representatives from each cluster are shown in Figure S1 (Text
S1) relative to the position of high affinity p53 helix. These
cluster representatives were produced by identifying the rotation
and translation that maps the hDM2 atoms used in the docking
run onto the 1T4F atoms, and applying the same rotation and
translation to the arylamide compound, allowing comparison of
the docked compounds to that of the high-affinity p53 peptide.
This produces two classes of potential binding complexes. The
first class consists of parallel conformations, which present their
C-terminus spatially proximal to the location of the C-terminus
of the p53 helix and their N-terminus spatially proximal to the
N-terminus of the helix, such as in conformation 4 in Figure 3.
The second class of anti-parallel conformations present their C-
terminus spatially proximal to the N-terminus of the p53 helix
and their N-terminus spatially proximal to the C-terminus of
the p53 helix, such as in conformations 1, 2, 3 and 8 in
Figure 3.
Molecular Docking is Suggestive of a Preference for Anti-
parallel Arylamide Conformations
Autodock sampling was performed again with more computa-
tionally expensive enhanced parameters that performed ten times
more energy evaluations in order to determine whether parallel or
anti-parallel hDM2-arylamide conformations might be more likely.
The results from the enhanced docking simulation are presented in
Figure 3, where the mean Autodock binding energy score is
presented for each of the clusters generated using a 2 Å RMSD
cutoff. The enhanced parameters for Autodock may show some
preference for anti-parallel arylamide conformations with a slight
bias to anti-parallel modes; however these calculations are only
suggestive of a bias towards anti-parallel conformations since
docking calculations do not properly sample the full thermody-
namic weights of configurations. Representative structures from
each of the large low energy clusters are shown inset, alongside a
representation of the high-affinity p53 helix shown in cyan
(Figure 3). Here we see that conformation 2 has the lowest energy
of about 211.8 kcal mol21, while conformation 1 also has a highly
populated cluster with mean Autodock energy of 210.8 kcal
mol21, a difference of only 1 kcal mol–1. We compare the energy
of the clusters to identify the likely binding mode, noting that that
highly populated clusters within 2.5 kcal mol-1 of each other are
unlikely to be distinguished from an incorrect binding mode [34].
There is significant literature suggesting that docking experiments
are not suitable to predict the binding affinity of protein-ligand
complexes, but they can still provide important information [48].
For example, Warren et al. found that docking programs often
identified the structure of the crystallographic ligand. However,
the scoring functions were often not able to identify the structure
of the crystallographic ligand as the lowest energy pose [48].
Previous work by Shaginian et al. presented only a parallel
binding mode when they used Autodock 3. However, because
their full methods were not presented, it is impossible to make
direct comparison to our results that show both parallel and anti-
parallel conformations [29]. The results shown in Figure 3 suggest
a possible bias towards anti-parallel conformations, with five of the
six large low energy clusters having this orientation. This bias may
be due to the fact that arylamide conformers are more stable in
their anti-parallel binding orientation, perhaps due to steric
clashes. Another hypothesis is that the negatively charged C-
terminus of the arylamide is favored in the region of the N-
terminus of the p53 helix, since the surface potential is slightly
positive in this region (Figure S4 in Text S1).
We also compared results from the rigid-body docking program
FRED, which uses conformers of ligands generated by OMEGA
and a static representation of the protein molecule, to the results
from Autodock. We tested the ability of Chemgauss 3, the
standard scoring function included with FRED, to identify likely
docked structures. However, we found that with Chemgauss 3
docked arylamides were often very exposed to the solvent in many
of the high ranked complexes (Figure S5 in Text S1). This result is
unphysical due to the hydrophobic nature of arylamide com-
pounds. When using FRED we observed 49 conformations in the
parallel conformation and 101 in the anti-parallel conformation.
As with the results from Autodock, even considering potential
issues with the Chemgauss 3 scoring function in this complex,
these results illustrate a significantly more complex picture than
the previously reported docked structure presented by Shaginian
et al. [29].
Stable Molecular Dynamics Simulations of HDM2-
arylamide Conformations Support the Binding Sites
Identified by Molecular Docking
If simulations of the hDM2-arylamide system had similar
stability to simulations of hDM2 complexes with known bound
structure, it would suggest that arylamides do indeed bind in the
p53 binding pocket as hypothesized by our structural superposi-
tion and molecular docking studies. We used a selection of starting
conformations generated in the docking results to start our MD
simulations. Figure 4 shows the RMSD/RMSF observed in the
molecular dynamics simulations. The RMSD from starting
structures stays within reasonable limits (,2 Å) and RMSF
between replicate simulations of the same complex is comparable.
These structural fluctuations are in good agreement with the
simulations of hDM2-p53, hDM2-Nutlin-2 and hDM2-benzodia-
zepinedione which remain similarly stable with equivalent RMSF
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(Text S1, Figure S6 and Figure S7). Specifically, both parallel and
anti-parallel arylamide starting conformations have an average
RMSD of less than 1.5 Å, with conformation 4 and conformation
3 occasionally slightly exceeding this value. In all cases RMSD
remains below 2 Å. RMS fluctuations are similar for both parallel
and anti-parallel simulations, and generally remain below a
maximum of 2 Å. For the hDM2 protein in the arylamide
complexes, there are regions of increased flexibility from residue
18–22, 44–47 and 69–77. The first two more flexible regions are
common to all arylamide simulations and the p53 and small
molecule simulations (Figure S6 in Text S1). These residues exist
at the N-terminus of the high-affinity p53 peptide structure, with
the glutamic acid in particular contacting the N-terminus of the
helix. These residues also form a short loop between a pair of beta
strands, which is likely to explain why the increased RMSF is
observed in all structures from both the arylamide simulations and
the initial MD simulations. The third flexible region in the
arylamide system is between residues 69–77. Equivalent higher
RMSF regions are not visible in Nutlin-2 and benzodiazepine
simulations (Text S1, Figure S6c residues 79–87 or Figure S6d
residues 69–77). The arylamide MD simulations exhibit RMSD
less than 2.5 Å throughout the simulation, indicating that they are
stable, and the RMSF, especially in the binding site, correlates well
with the RMSF observed in the simulations of peptides and small-
molecule binders (Figure S6 in Text S1). In summary, the similarly
low RMSD from initial structures in the arylamide simulations as
well as the mostly shared common areas of high and low
fluctuation between simulations of the arylamides and structurally
characterized binders suggest that the arylamides do indeed bind
in the same pocket as the p53 peptide.
In the case of MD simulations of p53 peptides and known small-
molecule inhibitors of hDM2, we observed that there was
fluctuation but little deviation from the initial value of the center
of mass distance between hDM2 and complexed ligand (Figure S8
in Text S1). This was likely due to the fact that the structures had
already reached an equilibrium ensemble. Figure 5 depicts the
number of contacts (defined as the number of intermolecular pairs
of atoms between hDM2 and the ligand that are within 3.5 Å) and
the differences in center of mass both of which provide a
quantitative measure of stability for the arylamide compounds in
the hDM2 binding site. Figure 5 shows results from parallel
arylamide starting configurations on the left and anti-parallel
arylamide starting configurations on the right. In the case of
hDM2 bound to the Phe-Nap-iPr arylamide, we know that not all
docked compounds can be in stable equilibrium states since we
have a variety of low energy docked complexes. Molecular
dynamics simulations of hDM2-arylamide starting conformations
identified by docking showed that the conformations tend to start
with around 125 contacts and may take up to 5 ns to reach the
equilibrium value of around 175 contacts (Figure 5). As the
number of contacts increases, the center of mass distance decreases
as the arylamide further explores tight fitting locations in the
hDM2 binding site. Figure 5 does indeed show that in some
simulations the average distance tends to decrease, a trend which
is more pronounced in the anti-parallel simulations (Figure 5d).
The decreased distance between centers of masses is particularly
obvious in the case of conformation 3 and is mirrored by an
increased number of contacts. Conformation 3 shows a decrease in
center of mass distance of 2 Å (Figure 5d, green line) and
additional increase in the number of contacting atoms (Figure 5b,
Figure 3. Mean Autodock binding energy score and corresponding cluster occupancy with a 2 Å RMSD cutoff. Representative
conformations used as initial conformations for MD simulations and the cluster from which they originated are highlighted. Highly populated clusters
with low mutual RMSD all exist within 2.5 kcal/mol, meaning that the docking scoring function is unable to determine a consensus bound
conformation.
doi:10.1371/journal.pone.0043253.g003
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green line), indicating that closer binding structures of the
arylamide to the protein continue to be explored as the system
equilibrates. The decrease in the center of mass is likely the result
of free rotation of the ArCO bond for the arylamide N-terminal
Phe group. Between 6 and 8 nanoseconds the Phe group rotated
from a bound conformation in the pocket towards the solvent,
between 8 and 9 nanoseconds the Phe group re-buried itself into
the pocket more deeply.
Initial analysis of these MD simulations shows that the RMSD
of each starting conformation relative to the docked structure is
very similar for both parallel and anti-parallel simulations. Both
parallel and anti-parallel conformations have similar deviation
from the initial structure over time. The RMSD, RMSF, number
of protein-ligand contacts and the protein-ligand center of mass
distances from our MD simulations suggest that simulations of
hDM2 with arylamides in the putative binding pocket behave
similarly to those of hDM2 in complex with p53 peptides or small-
molecule inhibitors. These dynamic structural similarities suggest
that the simulations of arylamide compounds bound to hDM2
properly reflect the likely binding locations.
Molecular Dynamics Simulations of Arylamide
Compounds in Both Parallel and Anti-parallel
Conformations are Consistent with Binding in the
Putative Binding Site
When proceeding with molecular dynamics simulations of
hDM2-arylamide conformations identified by docking, we choose
to use one representative structure from each of a group of docked
conformations. This structural diversity allows simulation of an
ensemble which would not otherwise be obtained with a single
starting configuration on the timescale of our simulations. For
example, we did not see anti-parallel and parallel starting
conformations interconvert on the timescale of our simulations.
However, using five anti-parallel starting conformations and four
parallel starting conformations, we were able to observe that some
of these conformations begin to converge to a common group
center for parallel and for anti-parallel simulations during the
Figure 4. Behavior of parallel (left) and anti-parallel (right) Phe-Nap-iPr conformations of the arylamide compound. a) RMSD relative
to initial minimized parallel conformation; b) RMSD relative to initial minimized anti-parallel conformation; c) RMS fluctuation of C-alpha atoms from
initial minimized parallel conformation; and d) RMS fluctuation of C-alpha atoms from initial minimized anti-parallel conformation. The RMSD
calculations tend to increase over time, but converge towards similar values after longer simulation times. The RMSF calculations exhibit similar
behavior to that observed in Figure S6 (Text S1), indicating that similar regions of the protein remain more flexible.
doi:10.1371/journal.pone.0043253.g004
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timescale of our simulations, resulting in partial convergence
towards a consensus structure for parallel or anti-parallel
conformations respectively. Not all arylamide compounds inter-
convert between clusters in our simulations, therefore we need to
consider each of these conformations in any conclusions of
equilibrium behavior. If we do not consider the individual starting
conformations, molecular dynamics will not sample all states
during the length of our simulations, which is of particular
importance when considering thermodynamic properties of the
hDM2-arylamide interaction. When arylamide conformations do
not interconvert we can consider the individual simulations as
sampling disjoint regions of phase space.
Orientation and Positioning of Arylamide Compounds in
the HDM2 Binding Pocket
We first investigate spatial sampling of the arylamides in the
hDM2 binding pocket. The orientation and positioning of
arylamide compounds in the hDM2 binding pockets is depicted
in Figures 6 and 7. Here we show the projection of ether oxygen
atoms from anti-parallel and parallel starting conformations onto a
plane defined by three Ca atoms in the binding site (more detailed
description of the projection is contained in the Methods section).
The diamond points in the graph show the starting conformation.
The N-terminal ether oxygen points are colored red, central ether
Figure 5. Time evolution of parallel (left) and anti-parallel (right) Phe-Nap-iPr arylamide conformations. a) the number of
intermolecular pairs of atoms between hDM2 and the ligand that are within 3.5 Å for parallel conformations; b) the number of intermolecular pairs of
atoms between hDM2 and the ligand that are within 3.5 Å for anti-parallel conformations; c) difference in protein-arylamide center of mass distance
(Å) from a minimized parallel starting conformation; and d) difference in protein-arylamide center of mass distance (Å) from a minimized anti-parallel
starting conformation. The number of contacts tends to increase, indicating increasing stability of the bound arylamide, although there is wider
variation in the number of contacts compared to the results presented in Figure S9 (Text S1). The hypothesis that an increasing number of contacts
indicates increasing stability is supported by the decrease in the distance between the centers of mass of arylamide and hDM2 as the simulations
progress, indicating a closer fit. It should be noted that decrease in the distance between centers of mass of ligand and protein is not always
indicative of greater ligand burial therefore a system specific decision must be made before employing this analysis technique.
doi:10.1371/journal.pone.0043253.g005
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oxygen points are colored black, and C-terminal ether oxygen
points are colored violet.
The anti-parallel arylamide starting conformations sampled
regions of the hDM2 binding pocket which overlap significantly
with the region of space sampled by the R-groups of the high
affinity p53 helix, as shown in Figure 6. In Figure 6b the arylamide
is skewed such that the C-terminal ether oxygens are more positive
in the x-direction and the N-terminal ether oxygens are more
negative in the x-direction. Since the end-to-end distance of the
arylamide compound stays approximately constant, the maximum
y-distance explored is slightly less in the case of b with respect to a
and e. Figure 6d shows similar behavior to what is observed in
Figure 6b, although the iPr side-chain is significantly rotated out of
the binding pocket at the start of the simulation due to a rotation
about the ArCO bond of the central benzene ring. This is evident
in the similar behavior of the R1 and R2 side-chains but the
heavily skewed distribution of the leucine R3 side-chain. Confor-
mation 3 in Figure 6c shows that the angle between the arylamide
and the plane is much closer to 90u rather than a desired planar
arrangement showing that the ligand is not bound in a similar
manner to the previously discussed simulations. However, it does
appear that this conformation samples the pocket quite differently
to the other conformations and represents a completely different
binding mode to that of the canonical helix form. Since we have
no evidence to discount this conformation as a possibility we must
explicitly consider this ‘‘perpendicular’’ configuration when
proceeding further with simulations.
In contrast, parallel arylamide conformations do not converge
structurally to a single ensemble. In the case of the parallel
arylamide conformations in Figure 7, particularly in 7a and 7b, the
C-terminus R3 of both simulations sample some of the same region
of phase space. However, it appears that the N-terminus R1 of the
two simulations explores a totally different region of space. This
observation suggests that the docked conformation is actually a
metastable state from which it decays into one of two or more
stable states. The simulation depicted in Figure 7b shows the N-
terminal phenylalanine remains in its rotated form (ArCO
dihedral such that the R1 group is opposite the R2 and R3 groups)
somewhat similar to the conformation in Figure 7d, while in
Figure 7a, this dihedral relaxes such that R1, R2 and R3 exist on
the same side.
Most Side Chain Dihedrals are Well Sampled on the 20 ns
Time Scale
Side chain dihedral angles can be some of the slowest
observables to properly converge in molecular dynamics simula-
tions, and observables such as binding free energies can
significantly depend on dihedral conformations [49]. We therefore
investigated the timescales of dihedral angle sampling in our
simulations. We examined both dihedral angles from the hDM2
binding site side-chains and dihedrals present in the arylamide
compound. We first examine which dihedral angles are likely to be
well- or poorly-sampled on the timescales of our simulations. We
then determine the relaxation time of the angle by fitting the
autocorrelation function of a dihedral angle to a simple
exponential model. The relaxation time corresponds to the
average time the simulation would need to run for the dihedral
angle to ‘forget’ information about its previous value. We can then
use correlation time to guide whether we need to use several
simulations with multiple starting configurations in the case of
large relaxation times or whether a single starting conformation
allows comprehensive sampling of the relevant regions of phase
space.
The dihedral distribution is plotted in Figure 8 for each of the
simulations and compared to the other distributions. The dihedral
is classified as ‘well sampled’ if all the distributions are in
agreement. The dihedral is labeled as ‘mostly well sampled’ if only
one of the distributions differs significantly from the others. The
dihedral is labeled as ‘poorly sampled’ if more than one
distribution contains a region that differs significantly between
simulations, which implies that more than one simulation does not
sample a possibly important region of dihedral space. In such
cases, it will significantly help to use multiple starting conforma-
tions to estimate thermodynamic properties as rotameric states
that are not sampled in a single simulation may contribute
significantly to the free energy of interaction [45].
The majority of dihedral angles within the arylamide com-
pounds in both parallel and anti-parallel starting conformations
are well sampled. Figure 8 shows a representation of the parallel
and anti-parallel Phe-Nap-iPr arylamide compounds. Bonds with
dihedral angles are shown in bold, with the quality of sampling of
the angle denoted by color. From a total of 16 dihedral angles
investigated, well-sampled dihedral angles (green) are observed in
10 parallel and 11 anti-parallel dihedral angles. There are three
mostly well-sampled dihedral angles (orange) from parallel
conformations and five mostly well-sampled dihedral angles in
the anti-parallel simulations. There are no poorly sampled
dihedral angles (red) in the anti-parallel conformations, while the
parallel conformations have poorly sampled dihedral angles for the
three x angles for the bonds attaching the 2-napthalene group. In
both cases, there are no aromatic residues that might restrict
dihedral sampling due to intermolecular p–p stacking effects,
assuming that the arylamide binding mode somewhat mimics that
of the p53 peptide (Figure S10 in Text S1).
Using the same three category classification scheme as used to
classify amino acid side chain dihedral angles for the arylamide
compound dihedral angles, we see in Figure 8 that dihedral angles
are often well sampled or mostly well sampled in both parallel and
anti-parallel simulations. In fact, from a total of 25 dihedral angles
we see only two poorly sampled dihedrals in the case of simulations
of the parallel binding configurations and only four poorly
sampled dihedrals in the case of simulations of the anti-parallel
binding configurations.
The relaxation times for hDM2 binding site residue dihedrals of
both the parallel and anti-parallel binding configurations are often
longer than the total length of the simulation (Text S1, Figure S11
and Figure S12). The long relaxation times observed for some
protein side chain dihedral angles means that some side chain
conformations are trapped, requiring that we consider multiple
simulation starting points when simulating these structures.
We use cluster analysis to track those conformations of the
arylamide compound occurring during our simulations and
observe which structural clusters interconvert on the timescale
of the simulations. Snapshots were taken every 10 ps for the
final 17 ns of simulation, resulting in a total of 8,500 anti-
parallel conformations of arylamides. When clustering anti-
parallel arylamide conformations we observe nearly 3000
members of the most populated cluster, 1500 for the second
most populated, approximately 1400 for the third most
populated and just short of 1250 for the fourth most populated.
The fifth most populated cluster has fewer than 500 members
(Figure S13 in Text S1). Although there are 33 clusters of anti-
parallel conformations in total, 84% of conformations are
contained in the four top ranked clusters. Figure 9 shows which
of the top four clusters (representative cluster members shown in
stick representation) are populated by arylamide conformations
from each of the five simulations as a function of time. We see
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that cluster four is visited predominantly by the simulation with
starting conformation one, however, it is also visited by
simulation 2 and 7. Thus the three starting conformations 1,
2 and 7 can likely be treated with a single simulation, since
each of these states is likely to be visited on the 20 ns time
scale. For simulations that are not converged one may expect
different average values when calculating using conformation 1,
2 or 7 as a starting point, however, for a simulation that
approaches thermodynamic convergence one would expect
average values to be comparable as the states can interchange
on these simulation timescales. In the case of cluster 2 and
cluster 3, we do not see any inter-conversion with other highly
populated clusters, thus 20 ns simulations must consider using
conformation 3 and 8 as starting points for simulation in
addition.
Figure 6. Orientation and positioning of arylamide compounds in the hDM2 binding pocket at 10 ps intervals. Four of five simulations
sample in the same region of space, whereas simulation c does not. Ether oxygens from anti-parallel conformations of Phe-Nap-iPr are projected onto
a plane defined by Ca atoms from Tyrosine 56, Methione 62 and Valine 93. Data points are color-coded depending on which ether oxygen they
belong to: R1 (Blue); R2 (Green); and R3 (Red). Data was plotted at 10 ps intervals starting after 4 ns of data collection. Values at t = 0 ps are plotted
with diamonds. Graphs show images of starting conformation relative to the high affinity p53 helix and data from: a) conformation 1; b) conformation
2; c) conformation 3; d) conformation 7; and e) conformation 8.
doi:10.1371/journal.pone.0043253.g006
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When clustering parallel simulations we observe approxi-
mately 1700 members in the most populated cluster, slightly
more than 1000 in the second most populated and just short of
900 in the third most populated cluster. There are 27 clusters in
total with more than 50% of conformers contained in the top 3
clusters. Parallel arylamide conformations show some inter-
conversion between low population clusters, but not significant
inter-conversion between the most occupied clusters. In
Figure 10 we show the representative member of each of the
top 3 clusters from parallel starting conformations. In this case,
it is immediately obvious that both clusters #2 and #3 are not
populated during the first 6 ns and 8 ns of the simulations.
However, after this time they begin to be occupied far more
often, implying that the ligand conformation converges towards
multiple structural clusters during the simulation. For simula-
tions of anti-parallel conformations we can conclude that there
is a reasonable amount of inter-conversion between clusters #1
and #4, hence it may be acceptable to choose only a single
representative to sample these states sufficiently. However, for
simulations of parallel conformations we conclude that several
favored conformations are identified (Figure 10), although inter-
conversion between these clusters does not occur on the 20 ns
time scale, suggesting that multiple starting conformations must
still be considered for further study.
Conclusions
The main aim of these experiments was to test the hypothesis
that arylamide alpha helical mimetics bind to the putative binding
Figure 7. Ether oxygens from parallel conformations of Phe-Nap-Leu projected onto a plane defined by Ca atoms from Tyrosine 56,
Methione 62 and Valine 93. Data points are color coded depending on which ether oxygen they belong to: R1 (Blue); R2 (Green); and R3 (Red).
Data points were plotted at 10 ps intervals starting after 4 ns of data collection. Values at t = 0 ps are plotted with diamonds. Graphs show image of
starting conformation and data from: a) conformation 4; b) conformation 9; c) conformation 10; and d) conformation 11.
doi:10.1371/journal.pone.0043253.g007
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site of hDM2 using docking and molecular dynamics simulations.
This detailed structural analysis of the binding site also helps
establish the structural properties of hDM2-arylamide binding for
use in further studies such as binding free energy calculations [50].
These results are especially important for synthetic chemists who
want to design new side chains for the arylamide compounds in
order to improve selectivity and affinity for the hDM2-p53
interaction and also for any further studies of the hDM2-p53
interaction using computational docking or molecular dynamics
techniques.
In this study, we have used a variety of techniques including
docking and molecular dynamics simulations in order to
investigate helix mimetic arylamide binding to hDM2. We showed
that the conformer generation program OMEGA is able to predict
the arylamides’ conformations. The widely used force fields of
GAFF and Autodock do not accurately predict the conformations
of the arylamides, while MMFF94 (used in Omega) could produce
plausible low energy arylamide conformers. We also showed that
the GAFF and Autodock force fields can be modified to improve
their performance in order to accurately reproduce the behavior of
arylamide backbones.
Simulations of hDM2 bound to arylamides are comparably
stable to those of hDM2 in complex with p53 peptides or
previously identified small-molecule inhibitors when using mea-
sures such as RMSD, RMSF, number of atomic contacts or
protein-ligand center of mass distance. This behavior validates our
choice of a force field designed to both simulate the properties of
the protein well and be compatible with the GAFF force field,
allowing the simulation of a large number of possible arylamide
side-chains. Alternative force fields, not tested in our study, may be
suitable for the study of arylamides in combination with proteins.
However, this experience suggests similar calculations to deter-
mine whether an alternative force field sufficiently reproduces
known experimental observations should be performed. This
finding also highlights the need to be cautious when applying such
ready-made force fields to atypical ligand chemistries. Researchers
should be prepared to perform QM in many cases. The ability to
compare with structural information on the ligand in solution may
also be necessary in the absence of structural information about
the bound complex.
We discovered that there are two classes of arylamide
conformation identified by docking which are stable in molecular
dynamics simulation: parallel and anti-parallel. Previous docking
studies only identified the parallel conformation [29]. However,
docking cannot distinguish which of these classes might be more
stable. It is likely, of course, that both are stable, and the closeness
in the stability suggests that it might be possible to bias one
conformation over another by altering the chemical groups
present on the arylamide side-chains. Such antiparallel configu-
rations must therefore be considered in future arylamide inhibitor
design. The possibility of steric clashes between parallel configu-
rations and the hDM2 protein suggests that it may be possible to
design inhibitors to adopt only parallel or anti-parallel configura-
tions by either promoting or reducing this clash as desired by
modification of the arylamide N-terminus. The compound studied
in this work, and related compounds studied in work by Plante
et al. are unlikely to have constituent side chains that are sufficient
to bias the orientation to consistently adopt only parallel or anti-
parallel conformations. Future design of arylamide compounds
that target charged residues at either end of the helix binding cleft
might be able to exploit charge complementary to bias towards
either parallel or anti-parallel binding.
Our procedure of extensive docking, combined with several
shorter molecular dynamics simulations identified several putative
Figure 8. Dihedral sampling of binding site hDM2 residues and arylamide bonds. 2D representations of a) parallel and b) anti-parallel
conformations of the Phe-Nap-iPr arylamide in the hDM2 binding site are produced using Ligplot [51]. Amino acid backbone residues and bonds with
no dihedrals are shown in grey, while arylamide torsions without flexible dihedrals are shown in purple. Rotatable bonds are colored according to our
sampling criteria with: green (well sampled); orange (well sampled in all but one simulation); red (poorly sampled across simulations). It is clear that
many dihedral angles are well sampled, but some are not, indicating that multiple starting configurations must be used for calculating
thermodynamic properties of the system.
doi:10.1371/journal.pone.0043253.g008
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metastable conformations, showing that single simulations of 20 ns
are not necessarily sufficient to capture the full functional flexibility
of hDM2-arylamide binding. In the section ‘Orientation and
positioning of arylamide compounds in the hDM2 binding pocket’, and
using cluster analysis, we identified two putative metastable
conformational states, based on the fact that of nine starting
conformations, five converged to sample the same two distinct
conformational ensembles. Inter-conversion between states, iden-
tified using cluster analysis, during the 20 ns simulations indicates
that a single starting conformation cannot be used to simulate the
equilibrium properties of the system. Because arylamide clusters
do not always inter-convert on the timescale of our simulations,
multiple starting conformations must be considered when inves-
tigating equilibrium properties of the system.
We have also presented a novel projection method to
characterize the spatial sampling in the hDM2 binding site,
which could be used in other protein binding studies. This
projection technique allows us to show how the arylamide
compounds sample the hDM2 binding site in space and time. In
combination with cluster analysis of arylamide conformations,
this procedure can characterize the convergence of arylamide
conformational ensembles. Such quantitative structural equili-
bration analysis techniques are currently rarely performed for
ligand binding. These techniques could easily be applied as a
straightforward method to determine structural sampling in
other protein-ligand systems, allowing researchers to visualize
the region of the binding pocket that is sampled by different
functional groups of a ligand.
When investigating the specific arylamide in our study we
showed the necessity of several techniques for improved
characterization of binding sites, such as the need to validate
sampling parameters used in docking, the use of clustering to
identify metastable states, and the need to characterize the
spatial sampling of the binding site. These techniques are likely
necessary for simulating a diverse range of arylamide and other
nonstandard chemical compounds, and more generally for
simulating binding pockets and designing drugs. The care
required to perform these sorts of analysis to truly identify
physically reasonable binding sites present a cautionary tale for
the use of molecular simulations to identify bound complexes of
novel classes of compounds.
Supporting Information
Text S1 Supporting Information. A Supporting Information
document is available in PDF format. It contains Supporting
Figures (Figures S1-S19), Methods and Tables from hDM2 binding
site analysis, docking calculations, arylamide charge derivation (see
Figure S14, Figure S15, Figure S16, Figure S17, Figure S18,
Figure S19) and hDM2/ arylamide conformational analysis.
(PDF)
File S1 Arylamide Conformations Zip. A zip file containing
PDB coordinates of the hDM2 structure 1T4F used for docking
Figure 9. Occupancy of the top four anti-parallel clusters. Color coded by starting conformation during the final 17 ns of the simulation. Initial
conformations 1, 2, and 7 interconvert between clusters #1 and #4.
doi:10.1371/journal.pone.0043253.g009
p53 Peptide Helix Mimetics Can Bind in Two Ways
PLOS ONE | www.plosone.org 15 August 2012 | Volume 7 | Issue 8 | e43253
and simulation, the docked arylamide conformations, and
Gromacs .itp files containing the arylamide bonded and non-
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